Follow
Leslie Cope
Leslie Cope
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network Tissue source sites: Duke University ...
Nature 455 (7216), 1061-1068, 2008
72952008
Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
67672011
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
DT Le, JN Durham, KN Smith, H Wang, BR Bartlett, LK Aulakh, S Lu, ...
Science 357 (6349), 409-413, 2017
59502017
Summaries of Affymetrix GeneChip probe level data
RA Irizarry, BM Bolstad, F Collin, LM Cope, B Hobbs, TP Speed
Nucleic acids research 31 (4), e15-e15, 2003
59342003
affy—analysis of Affymetrix GeneChip data at the probe level
L Gautier, L Cope, BM Bolstad, RA Irizarry
Bioinformatics 20 (3), 307-315, 2004
56122004
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
42862018
Comprehensive molecular profiling of lung adenocarcinoma
Cancer Genome Atlas Research Network
Nature 511 (7511), 543, 2014
37842014
Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network
Nature 489 (7417), 519, 2012
36282012
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma
H Noushmehr, DJ Weisenberger, K Diefes, HS Phillips, K Pujara, ...
Cancer cell 17 (5), 510-522, 2010
26962010
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
26302015
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
24942018
Integrated genomic characterization of papillary thyroid carcinoma
N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ...
Cell 159 (3), 676-690, 2014
24572014
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
23742018
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
21052018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
19762018
Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses
KB Chiappinelli, PL Strissel, A Desrichard, H Li, C Henke, B Akman, ...
Cell 162 (5), 974-986, 2015
16862015
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1641*2020
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
15272018
A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing
JE Ohm, KM McGarvey, X Yu, L Cheng, KE Schuebel, L Cope, ...
Nature genetics 39 (2), 237-242, 2007
12432007
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
JD Campbell, A Alexandrov, J Kim, J Wala, AH Berger, CS Pedamallu, ...
Nature genetics 48 (6), 607-616, 2016
11022016
The system can't perform the operation now. Try again later.
Articles 1–20